With 30% to 40% of people in the workforce at risk for prediabetes, it is important for employers to embrace diabetes prevention in the workplace, said Paul Chew, MD, chief medical officer of Omada Health.
With 30% to 40% of people in the workforce at risk for prediabetes, it is important for employers to embrace diabetes prevention in the workplace, said Paul Chew, MD, chief medical officer of Omada Health.
Transcript
Why is it important to engage employers in diabetes prevention?
Omada is approaching a problem that is found with every workforce. We estimate that 30% to 40% of people in the American workforce may be at risk for prediabetes. What elevates the risk? If you’re 45 or older, if you have a close relative with diabetes, if you’re a member of a minority group, if you’re overweight or obese. Those factors are found in a large number of Americans in the workforce. We feel strongly that the workforce, where you spend so much of your time, is a great opportunity for employers to reduce their costs and to improve the overall health, well-being, and enthusiasm of their employees.
How should an employer evaluate a digital health?
One of the most important things that faces employers—in fact, the nation overall--is the ballooning cost of healthcare. For employers, I would suggest they look at their organizations for the major healthcare costs, and I’m sure it will be diabetes, cardiovascular diseases, and obesity at the top. They should look at potential solutions that can reach the broadest number of people when they need it, when they want it, at home, at the office, or even at restaurants, where they can access a digital program. They should look for publications that validate this particular company’s approach in terms of clinical outcomes and return on investment. They should also look at a digital solution or a face-to-face solution that can be accessed and help the employer reach as many of their employees as possible. We know there are initiatives that are just not taken up because the approach or engagement of employees is just not there.
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Getting to Know Dr Fabiola Molina, Hospitalist
February 26th 2024Fabiola Molina, MD, MHS, is a practicing hospitalist and assistant professor of medicine at Yale School of Medicine and Yale New Haven Hospital. An immigrant from Mexico, her experiences straddling 2 worlds, while attempting to navigate with her family the complicated safety-net system for health care in Texas, were key influences to her ardent focus on health equity.
Read More